Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.

This bill (S 518) amends New Jersey's prescription monitoring program to clarify who can access patient prescription data. It updates Section 26 of the existing law to specify that healthcare providers (including pharmacists, medical residents, certified medical assistants, and others) must register to access the system and must delegate access to staff under strict confidentiality rules. The bill does not include provisions allowing patients to indicate preferences about receiving certain prescriptions, as suggested in the title. The actual focus is on defining access protocols for authorized healthcare professionals to review prescription data for patient safety and compliance purposes. The bill was introduced to the Senate Health Committee on January 13, 2026.